Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.62)
# 2,798
Out of 4,411 analysts
98
Total ratings
35.3%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AIM: AMS Advanced Medical Solutions Group plc | Maintained: Buy | 245p | $215.00 | +13.95% | 12 | May 21, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | $209.00 | +50.72% | 10 | Mar 11, 2026 | |
| PLLWF Polarean Imaging plc | Maintained: Buy | $0.11 → $0.05 | $0.0066 | +713.68% | 9 | Sep 25, 2025 | |
| AIM: DXRX Diaceutics PLC | Maintained: Buy | 225p | $142.50 | +57.89% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Maintained: Buy | 29p → 35p | $26.44 | +32.36% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Maintained: Hold | 1,850p → 2,300p | $2,216.00 | +3.79% | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | $1,467.00 | n/a | 8 | Apr 24, 2025 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 398p → 411p | $416.00 | n/a | 5 | Mar 21, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Reiterated: Buy | €4.00 | $0.85699999 | n/a | 3 | Nov 19, 2024 | |
| AMS: PHARM Pharming Group N.V. | Reiterated: Buy | n/a | $1.09 | n/a | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 105p | $73.00 | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €109.00 | $68.35 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €226.47 → €244.55 | $23.40 | n/a | 9 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,469p → 4,097p | $7.50 | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,076p → 5,586p | $49.50 | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,493p → 14,003p | $66.40 | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 13,035p | $0.1915 | n/a | 3 | May 18, 2017 |
Advanced Medical Solutions Group plc
May 21, 2026
Maintained: Buy
Price Target: 245p
Current: $215.00
Upside: +13.95%
Convatec Group PLC
Mar 11, 2026
Reiterated: Buy
Price Target: 315p
Current: $209.00
Upside: +50.72%
Polarean Imaging plc
Sep 25, 2025
Maintained: Buy
Price Target: $0.11 → $0.05
Current: $0.0066
Upside: +713.68%
Diaceutics PLC
Sep 23, 2025
Maintained: Buy
Price Target: 225p
Current: $142.50
Upside: +57.89%
EKF Diagnostics Holdings plc
Sep 16, 2025
Maintained: Buy
Price Target: 29p → 35p
Current: $26.44
Upside: +32.36%
Genus plc
Sep 9, 2025
Maintained: Hold
Price Target: 1,850p → 2,300p
Current: $2,216.00
Upside: +3.79%
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: $1,467.00
Upside: n/a
Uniphar plc
Mar 21, 2025
Reiterated: Buy
Price Target: 398p → 411p
Current: $416.00
Upside: n/a
Nanoform Finland Oyj
Nov 19, 2024
Reiterated: Buy
Price Target: €4.00
Current: $0.85699999
Upside: n/a
Pharming Group N.V.
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.09
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: 105p
Current: $73.00
Upside: n/a
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: $68.35
Upside: n/a
Nov 12, 2018
Reiterated: Buy
Price Target: €226.47 → €244.55
Current: $23.40
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,469p → 4,097p
Current: $7.50
Upside: n/a
May 24, 2018
Maintained: Buy
Price Target: 7,076p → 5,586p
Current: $49.50
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,493p → 14,003p
Current: $66.40
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 13,035p
Current: $0.1915
Upside: n/a